The influence of balneo- and peloid therapy on the characteristics of the hormonal regulation in the women presenting with bacterial vaginosis

Boldyreva O.A.

Krymskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. S.I. Georgievskogo

Authors:

Boldyreva O.A.

More about the authors

Journal: Problems of Balneology, Physiotherapy and Exercise Therapy. 2015;92(3): 22‑26

DOI: 10.17116/kurort2015322-26

Downloaded: 22

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Boldyreva OA. The influence of balneo- and peloid therapy on the characteristics of the hormonal regulation in the women presenting with bacterial vaginosis. Problems of Balneology, Physiotherapy and Exercise Therapy. 2015;92(3):22‑26. (In Russ.)
https://doi.org/10.17116/kurort2015322-26

Подписка 2025 (Problems of Balneology, Physiotherapy and Exercise Therapy)

Close metadata

Recommended articles:

Hyperprolactinaemia and reproductive health of women. Russian Bulletin of Obstetrician-Gynecologist. 2024;(1):41-46

Aim. The objective of the present work was to study the influence of balneo- and peloid therapy on the characteristics of the hormonal regulation in the women presenting with bacterial vaginosis Materials and methods. The immunoenzymatic assay (ELISA) was used to study characteristics of hormonal regulation in 128 women presenting with bacterial vaginosis and normal prolactin level and 58 women with bacterial vaginosis and concomitant hyperprolactinemia. The study included the evaluation of dynamics of the clinical and laboratory parameters under the influence of peloidtherapy. Results. The application of the sulfide-containing siltypeloids was shown to have positive clinical effect on the adrenal and ovarian function and to exert the modulating action on the levels of the pituitary and sex hormones in women with bacterial vaginosis and normal prolactin levels. In contrast, the same treatment of the women with bacterial vaginosis and hyperprolactinemia causes a further deterioration of hormonal imbalance, increases the initially elevated prolactin level, aggravates disorders in the pituitary and ovarian regulation, and decreases the effectiveness of the treatment. Conclusion. The results of the study suggest the necessity of the differential approach to the prescription of balneo- and peloid therapy to the patients with gynecological problems associated with hormonal disorders taking into account the level of prolactinemia.

Keywords:

bacterial vaginosis

hyperprolactinemia

peloidtherapy

Authors:

Boldyreva O.A.

Krymskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. S.I. Georgievskogo

List of references:

Kosej N, Tatarchuk T, Vetoh G. Empirical therapy of vaginitis as a method to prevent ascending infection. Reproduktivnaja jendokrinologija. 2012;2(4):70-74. (in Russ.)
Management of patients with vaginal discharge. Reproduktivnaja jendokrinologija. 2012;3(5):22-31. (in Russ.)
Kuz'min V, Murrieva G. The role of nonspecific urogenital infections in the pathogenesis of spontaneous preterm birth. Lechashhij vrach. 2013;6:60-62. (in Russ.)
Radzinskij V, Ordijanc I, Chetvertakova Je, Misuno O. Two-stage treatment of vaginal infections. Akusherstvo i ginekologija. 2011;5:78-81. (in Russ.)
Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006;193:1479-1486.
Larsson PG, Brandsborg E, Forsum U et al. Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses. BMC Infect Dis. 2011;11:223.
Makarova O, Aleshkina V, Savchenko T. Infections in obstetrics and gynecology. Moscow: MEDpress-inform; 2007:177-189. (in Russ.)
Kalinin V. Physiology of pelotherapy as a special case of nonspecific adaptation. Voprosy kurortologii, fizioterapii i LFK. 2003;4:52-54. (in Russ.)
Kulikov V. Sanogenetic mechanisms pelotherapy. Novosibirsk: NGMI; 1999. (in Russ.)
Nazarov P, Isaev M. The lipid composition of curative mud. Voprosy kurortologii, fizioterapii i LFK. 2003;5:46-47. (in Russ.)
Pristupjuk A. Syndrome of hyperprolactinemia. Mezhdunarodnij endokrinologicheskij zhurnal. 2012;6(46):63-69. (in Russ.)
Vihljaeva E. Rukovodstvo po jendokrinnoj ginekologii. Moscow: MIA; 2006:366-389. (in Russ.)
Ismail MS, Serour GI, Torsten U. Elevated serum prolactin level with high-dose estrogen contraceptive pills. Eur J Contracept Reprod Health Care. 1998;3(1):45-50.
Testa G, Vegetti W, Motta T. Two-year treatment with oral contraceptives in hyperprolactinemic patients. Contraception. 1998;5(2):69-73.
Dedov I, Mel'nichenko G, Romancova T. Syndrome of hyperprolactinemia. Moscow-Tver': Triada; 2004. (in Russ.)
Tatarchuk T, Sol'skij Ja. Endocrine gynecology. Kiev: Zapovit; 2003. (in Russ.)
Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. The journal of clinical endocrinology and metabolism. 2011; 96(2): 273-288.

Close metadata